본문 바로가기
KERD
논문KCI 등재

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: A Genetic Cause of Cerebral Small Vessel Disease

최재철
대한신경과학회 (Korean Neurological Association)|2010.03|Journal of Clinical Neurology|제6권 제1호|pp. 1-9

2

조회

0

다운로드

6

인용

0

참고문헌

키워드

migraineischemic strokesmall-vessel diseaseNotch3.

초록

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a single-gene disorder of the cerebral small blood vessels caused by mutations in the Notch3 gene. The exact prevalence of this disorder was unknown currently, and the number of reported CADASIL families is steadily increasing as the clinical picture and diagnostic examinations are becoming more widely known. The main clinical manifestations are recurrent stroke, migraine, psychiatric symptoms, and progressive cognitive impairment. The clinical course of CADASIL is highly variable, even within families. The involvement of the anterior temporal lobe and the external capsule on brain magnetic resonance imaging was found to have high sensitivity and specificity in differentiating CADASIL from the much more common sporadic cerebral small-vessel disease (SVD). The pathologic hallmark of the disease is the presence of granular osmiophilic material in the walls of affected vessels. CADASIL is a prototype single-gene disorder that has evolved as a unique model for studying the mechanisms underlying cerebral SVD. At present, the incidence and prevalence of CADASIL seem to be underestimated due to limitations in clinical, neuroradiological, and genetic diagnoses of this disorder.

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a single-gene disorder of the cerebral small blood vessels caused by mutations in the Notch3 gene. The exact prevalence of this disorder was unknown currently, and the number of reported CADASIL families is steadily increasing as the clinical picture and diagnostic examinations are becoming more widely known. The main clinical manifestations are recurrent stroke, migraine, psychiatric symptoms, and progressive cognitive impairment. The clinical course of CADASIL is highly variable, even within families. The involvement of the anterior temporal lobe and the external capsule on brain magnetic resonance imaging was found to have high sensitivity and specificity in differentiating CADASIL from the much more common sporadic cerebral small-vessel disease (SVD). The pathologic hallmark of the disease is the presence of granular osmiophilic material in the walls of affected vessels. CADASIL is a prototype single-gene disorder that has evolved as a unique model for studying the mechanisms underlying cerebral SVD. At present, the incidence and prevalence of CADASIL seem to be underestimated due to limitations in clinical, neuroradiological, and genetic diagnoses of this disorder.

참고문헌 (71)

  1. Ringelstein EB, "Cerebral small vessel diseases:cerebral microangiopathies", Curr Opin Neurol, 18, pp.179~188 (2005)
  2. Joutel A, "Notch3 mutations in CADASIL,a hereditary adult-onset condition causing stroke and dementia", Nature, 383, pp.707~710 (1996)
  3. Bousser MG, "Summary of the proceedings of the First International Workshop on CADASIL.Paris,May 19-21,1993", Stroke, 25, pp.704~707 (1994)
  4. Sourander P, "Hereditary multi-infarct dementia.Morphological and clinical studies of a new disease", Acta Neuropathol, 39, pp.247~254 (1977)
  5. Stevens DL, "Chronic familial vascular encephalopathy", Lancet, 1, pp.1364~1365 (1977)
  6. Low WC, "Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL", Brain, 130(Pt 2), pp.357~367 (2007)
  7. Tournier-Lasserve E, "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12", Nat Genet, 3, pp.256~259 (1993)
  8. Joutel A, "Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients", Lancet, 350, pp.1511~1515 (1997)
  9. Razvi SS, "The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy(CADASIL)in the west of Scotland", J Neurol Neurosurg Psychiatry, 76, pp.739~741 (2005)
  10. Dong Y, "Yield of screening for CADASIL mutations in lacunar stroke and leukoaraiosis", Stroke, 34, pp.203~205 (2003)
  11. Chabriat H, "Clinical spectrum of CADASIL:a study of 7 families.Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Lancet, 346, pp.934~939 (1995)
  12. Dichgans M, "The phenotypic spectrum of CADASIL:clinical findings in 102 cases", Ann Neurol, 44, pp.731~739 (1998)
  13. van den Boom R, "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy:MR imaging findings at different ages-3rd-6th decades", Radiology, 229, pp.683~690 (2003)
  14. Mykkanen K, "Detection of the founder effect in Finnish CADASIL families", Eur J Hum Genet, 12, pp.813~819 (2004)
  15. Opherk C, "Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients", Brain, 127(Pt 11), pp.2533~2539 (2004)
  16. Singhal S, "The influence of genetic and cardiovascular risk factors on the CADASIL phenotype", Brain, 127(Pt 9), pp.2031~2038 (2004)
  17. Dotti MT, "The spectrum of Notch3 mutations in 28 Italian CADASIL families", J Neurol Neurosurg Psychiatry, 76, pp.736~738 (2005)
  18. Artavanis-Tsakonas S, "Notch signaling:cell fate control and signal integration in development", Science, 284, pp.770~776 (1999)
  19. Joutel A, "The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients", J Clin Invest, 105, pp.597~605 (2000)
  20. Alva JA, "Notch signaling in vascular morphogenesis", Curr Opin Hematol, 11, pp.278~283 (2004)
  21. Joutel A, "Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP", JK signaling pathway, 2004, pp.74, 338~347
  22. Monet-Lepretre M, "Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain", Brain, 132(Pt 6), pp.1601~1612 (2009)
  23. Opherk C, "CADASIL mutations enhance spontaneous multimerization of NOTCH3", Hum Mol Genet, 18, pp.2761~2767 (2009)
  24. Tikka S, "Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients", Brain, 132(Pt 4), pp.933~939 (2009)
  25. Kim Y, "Two novel mutations of the NOTCH3 gene in Korean patients with CADASIL", Mutat Res, 593, pp.116~120 (2006)
  26. Kim Y, "Characteristics of CADASIL in Korea:a novel cysteine-sparing Notch3 mutation", Neurology, 66, pp.1511~1516 (2006)
  27. Mazzei R, "A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL", Neurology, 63, pp.561~564 (2004)
  28. Okeda R, "Arterial changes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy(CADASIL)in relation to pathogenesis of diffuse myelin loss of cerebral white matter:examination of cerebral medullary arteries by reconstruction of serial sections of an autopsy case", Stroke, 33, pp.2565~2569 (2002)
  29. Scheid R, "Cysteine-sparing notch3 mutations:cadasil or cadasil variants?", Neurology, 71, pp.774~776 (2008)
  30. Coto E, "A new de novo Notch3 mutation causing CADASIL", Eur J Neurol, 13, pp.628~631 (2006)
  31. Joutel A, "De novo mutation in the Notch3 gene causing CADA SIL", Ann Neurol, 47, pp.388~391 (2000)
  32. Tuominen S, "Phenotype of a homozygous CADASIL patient in comparison to 9 age-matched heterozygous patients with the same R133C Notch3 mutation", Stroke, 32, pp.1767~1774 (2001)
  33. Lee YC, "Population-specific spectrum of NOTCH3 mutations,MRI features and founder effect of CADASIL in Chinese", J Neurol, 256, pp.249~255 (2009)
  34. Kang SY, "Nerve conduction studies in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", J Neurol, 256, pp.1724~1727 (2009)
  35. Fouillade C, "Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain", Hum Mutat, 29, pp.452~ (2008)
  36. Ruchoux MM, "CADASIL:cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", J Neuropathol Exp Neurol, 56, pp.947~964 (1997)
  37. Viswanathan A, "Cortical neuronal apoptosis in CADASIL", Stroke, 37, pp.2690~2695 (2006)
  38. Miao Q, "Fibrosis and stenosis of the long penetrating cerebral arteries:the cause of the white matter pathology in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Brain Pathol, 14, pp.358~364 (2004)
  39. Miao Q, "Arterioles of the lenticular nucleus in CADASIL", Stroke, 37, pp.2242~2247 (2006)
  40. Baudrimont M, "Autosomal dominant leukoencephalopathy and subcortical ischemic stroke.A clinicopathological study", Stroke, 24, pp.122~125 (1993)
  41. Ishiko A, "Notch3 ectodomain is a major component of granular osmiophilic material(GOM)in CADASIL", Acta Neuropathol, 112, pp.333~339 (2006)
  42. Ruchoux MM, "Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Acta Neuropathol, 89, pp.500~512 (1995)
  43. Ruchoux MM, "Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL", Stroke, 25, pp.2291~2292 (1994)
  44. Desmond DW, "The natural history of CADASIL:a pooled analysis of previously published cases", Stroke, 30, pp.1230~1233 (1999)
  45. Choi EJ, "Large cerebral artery involvement in CADASIL", Neurology, 65, pp.1322~1324 (2005)
  46. Choi JC, "Intracerebral hemorrhages in CADASIL", Neurology, 67, pp.2042~2044 (2006)
  47. Peters N, "A two-year clinical follow-up study in 80 CADASIL subjects:progression patterns and implications for clinical trials", Stroke, 35, pp.1603~1608 (2004)
  48. Buffon F, "Cognitive profile in CADASIL", J Neurol Neurosurg Psychiatry, 77, pp.175~180 (2006)
  49. Charlton RA, "The cognitive profiles of CADASIL and sporadic small vessel disease", Neurology, 66, pp.1523~1526 (2006)
  50. Liem MK, "Lacunar infarcts are the main correlate with cognitive dysfunction in CADASIL", Stroke, 38, pp.923~928 (2007)
  51. Santa Y, "Genetic,clinical and pathological studies of CADASIL in Japan:a partial contribution of Notch3 mutations and implications of smooth muscle cell degeneration for the pathogenesis", J Neurol Sci, 212, pp.79~84 (2003)
  52. Valenti R, "Psychiatric disturbances in CADASIL:a brief review", Acta Neurol Scand, 118, pp.291~295 (2008)
  53. Reyes S, "Apathy:a major symptom in CADASIL", Neurology, 72, pp.905~910 (2009)
  54. Zicari E, "Right-to-left shunt in CADASIL patients:prevalence and correlation with clinical and MRI findings", Stroke, 39, pp.2155~2157 (2008)
  55. Chabriat H, "Patterns of MRI lesions in CADASIL", Neurology, 51, pp.452~457 (1998)
  56. O’Sullivan M, "MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL", Neurology, 56, pp.628~634 (2001)
  57. Viswanathan A, "Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL", Neurology, 69, pp.172~179 (2007)
  58. Viswanathan A, "Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study", Brain, 129(Pt 9), pp.2375~2383 (2006)
  59. Holtmannspotter M, "Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL:a two-year follow-up study", Stroke, 36, pp.2559~2565 (2005)
  60. Peters N, "Brain volume changes in CADASIL:a serial MRI study in pure subcortical ischemic vascular disease", Neurology, 66, pp.1517~1522 (2006)
  61. Mellies JK, "SPECT study of a German CADASIL family:a phenotype with migraine and progressive dementia only", Neurology, 50, pp.1715~1721 (1998)
  62. Chabriat H, "Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking", Stroke, 31, pp.1904~1912 (2000)
  63. Tuominen S, "Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients", Stroke, 35, pp.1063~1067 (2004)
  64. Razvi SS, "Is inadequate family history a barrier to diagnosis in CADASIL?", Acta Neurol Scand, 112, pp.323~326 (2005)
  65. Ebke M, "CADASIL:skin biopsy allows diagnosis in early stages", Acta Neurol Scand, 95, pp.351~357 (1997)
  66. Markus HS, "Diagnostic strategies in CADASIL", Neurology, 59, pp.1134~1138 (2002)
  67. Joutel A, "Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis", Lancet, 358, pp.2049~2051 (2001)
  68. Forteza AM, "Acetazolamide for the treatment of migraine with aura in CADASIL", Neurology, 57, pp.2144~2145 (2001)
  69. Weller M, "Acetazolamide-responsive migraine in CADASIL", Neurology, 50, pp.1505~ (1998)
  70. Dichgans M, "Donepezil in patients with subcortical vascular cognitive impairment:a randomised double-blind trial in CADASIL", Lancet Neurol, 7, pp.310~318 (2008)
  71. Dichgans M, "Angiographic complications in CADASIL", Lancet, 349, pp.776~777 (1997)

관련 논문AI추천

Update on the Epidemiology, Pathogenesis, and Biomarkers of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy최재철, Masafumi Ihara, Yi-Chu Liao, Yi-Chung Lee, Yumi Yamamoto대한신경과학회 · Journal of Clinical Neurology2023 · 제19권 제1호Phenotypic Features of Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Subjects with R544C Mutation오정환, 이정석, Ho Kyu Lee, Joon Hyuk Park, KeunHyuk Ko대한치매학회 · Dementia and Neurocognitive Disorders(대한치매학회지)2016 · 제15권 제1호Elderly CADASIL patients with intact neurological statusElisabeth Tournier-Lasserve, Elisa Ouin, Eric Jouvent, Hugues Chabriat, Jessica Lebenberg, Karine Ighilkrim, Lina Grosset, Ruiting Zhang, Stéphanie Guey, Véronique François대한뇌졸중학회 · 대한뇌졸중영문학회지2022 · 제24권 제3호Effects of Lacunar Infarctions on Cognitive Impairment in Patients with Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy강사윤, 강지훈, 나해리, 박지강, 이정석, 최재철대한신경과학회 · Journal of Clinical Neurology2011 · 제7권 제4호Possible Role of a Missense Mutation of p.P167S on NOTCH3 Gene Associated with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy김희진, 박성호, Byung Woo Choi대한치매학회 · Dementia and Neurocognitive Disorders(대한치매학회지)2016 · 제15권 제2호Eighteen-Year Disease Progression and Survival in CADASILAnna M. van Opstal, Annemieke Aartsma-Rus, Bastian J. van Eijsden, Gido Gravesteijn, Huub A.M. Middelkoop, Jeroen van de Grond, Julie W. Rutten, Mar D.M. Rodriguez Girondo, Remco J. Hack, Saskia A.J. Lesnik Oberstein대한뇌졸중학회 · 대한뇌졸중영문학회지2021 · 제23권 제1호

이 간행물의 다른 논문 (7건)

Will Molecular Optical Imaging Have Clinically Important Roles in Stroke Management, and How?이동근, Dawid Schellingerhout, Matthias Nahrendorf, 김동억pp. 10-18Can Early Ischemic Lesion Recurrence on Diffusion-Weighted MRI Affect Functional Outcome after Acute Ischemic Stroke?양미화, 고영채, 배희준, 장명석, 한문구, 박성호, 김욱주, 김재형, 박정현, 김상윤pp. 19-26Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled Trial박정욱, 조용진, 오경미, 주민경, 정형기, 도진국, 김응규, 정재면, 권순억, 한설희pp. 27-32Diagnostic Value of Cerebrospinal Fluid Level of Carcinoembryonic Antigen in Patients with Leptomeningeal Carcinomatous Metastasis하윤석, 허소영, 강성진, 김광수, 김민정, 이지현, 김종국pp. 33-37Early Dorsal Midbrain Syndrome Mimicking an Adie’s Tonic Pupil김정연, 한상원, 백종삼, 황용순, 류정호, 박재현pp. 38-40
원문 보기